Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus

References

• Chambers HF, Deleo FR. Waves of resistance: staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7:629–641.
   PubMed Web of Science ®Google Scholar
• Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033.
   PubMed Web of Science ®Google Scholar
• McGuinness WA, Malachowa N, DeLeo FR. Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med. 2017;90:269–281.
   PubMed Web of Science ®Google Scholar
• Jian J, Chen L, Xie Z, et al. Dissemination of cfr-mediated linezolid resistance among Staphylococcus species isolated from a teaching hospital in Beijing, China. J Int Med Res. 2018;46:3884–3889.
   PubMed Web of Science ®Google Scholar
• Kim W, Hendricks GL, Tori K, et al. Strategies against methicillin-resistant Staphylococcus aureus persisters. Future Med Chem. 2018;10:779–794.
   PubMed Web of Science ®Google Scholar
• Kobayashi SD, Malachowa N, DeLeo FR. Pathogenesis of Staphylococcus aureus abscesses. Am J Pathol. 2015;185:1518–1527.
   PubMed Web of Science ®Google Scholar
• Larru B, Gerber JS. Cutaneous bacterial infections caused by Staphylococcus aureus and Streptococcus pyogenes in infants and children. Pediatr Clin North Am. 2014;61:457–478.
   PubMed Web of Science ®Google Scholar
• Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system. JAMA. 2012;308:50–59.
   PubMed Web of Science ®Google Scholar
• Konig C, Simmen HP, Blaser J. Bacterial concentrations in pus and infected peritoneal fluid-implications for bactericidal activity of antibiotics. J Antimicrob Chemother. 1998;42:227–232.
   PubMed Web of Science ®Google Scholar
• DiMasi JA. Risks in new drug development: approval success rates for investigational drugs. Clin Pharmacol Ther. 2001;69:297–307.
   PubMed Web of Science ®Google Scholar
• DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22:151–185.
   PubMed Web of Science ®Google Scholar
• Thakare R, Shukla M, Kaul G, et al. Repurposing disulfiram for treatment of Staphylococcus aureus infections. Int J Antimicrob Agents. 2019;53:709–715.
   PubMed Web of Science ®Google Scholar
• Sekine L, Morais VD, Lima KM, et al. Conventional and high-dose daunorubicin and idarubicin in acute myeloid leukaemia remission induction treatment: a mixed treatment comparison meta-analysis of 7258 patients. Hematol Oncol. 2015;33:212–219.
   PubMed Web of Science ®Google Scholar
• Marinello J, Delcuratolo M, Capranico G. Anthracyclines as topoisomerase II poisons: from early studies to new perspectives. Int J Mol Sci. 2018;19(11):E3480.
   PubMed Web of Science ®Google Scholar
• Kinnunen U, Koistinen P, Syrjälä H, et al. Effects of anti-neoplastic agents on the recovery of bacteria and yeasts in an automated blood culture system. Scand J Infect Dis. 2000;32:63–67.
   PubMedGoogle Scholar
• Peiris V, Oppenheim BA. Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures. J Clin Pathol. 1993;46:1124–1125.
   PubMed Web of Science ®Google Scholar
• Harbut MB, Vilcheze C, Lu X, et al. Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proc Natl Acad Sci U S A. 2015;112:4453–4458.
   PubMed Web of Science ®Google Scholar
• Carcamo-Noriega EN, Sathyamoorthi S, Banerjee S, et al. 1,4-Benzoquinone antimicrobial agents against Staphylococcus aureus and Mycobacterium tuberculosis derived from scorpion venom. Proc Natl Acad Sci U S A. 2019;116:12642–12647.
   PubMed Web of Science ®Google Scholar
• Lee YS, Jang KA, Cha JD. Synergistic antibacterial effect between silibinin and antibiotics in oral bacteria. J Biomed Biotechnol. 2012;2012:618081.
   PubMedGoogle Scholar
• de Breij A, Riool M, Cordfunke RA, et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med. 2018;10:eaan4044
   Google Scholar
• Jiang Q, Jin Z, Sun B. MgrA negatively regulates biofilm formation and detachment by repressing the expression of psm operons in Staphylococcus aureus. Appl Environ Microbiol. 2018;84:e01008–18.
   PubMed Web of Science ®Google Scholar
• Gomes FI, Teixeira P, Azeredo J, et al. Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis. Curr Microbiol. 2009;59:118–122.
   PubMed Web of Science ®Google Scholar
• Kim W, Zou G, Hari TPA, et al. A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 2019;116:16529–16534.
   PubMed Web of Science ®Google Scholar
• Van Der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26:1701–1718.
   PubMed Web of Science ®Google Scholar
• Weigend F, Ahlrichs R. Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: design and assessment of accuracy. Phys Chem Chem Phys. 2005;7:3297–3305.
   PubMed Web of Science ®Google Scholar
• Hess B, Bekker H, Berendsen HJC, et al. LINCS: A linear constraint solver for molecular simulations. J Chem Theory Comput. 1997;4:1463–1472.
   Google Scholar
• Darden TA, York DM, Pedersen LG. Particle mesh Ewald-an N.log(N) method for Ewald sums in large systems. J Chem Phys. 1992;98::10089–92.
   Web of Science ®Google Scholar
• Berendsen HJC, Postma JPM, Van Gunsteren WF, et al. Molecular dynamics with coupling to an external bath. J Chem Phys. 1984;81:3684–3690.
   Web of Science ®Google Scholar
• Martonák R, Laio A, Parrinello M. Predicting crystal structures: the Parrinello-Rahman method revisited. Phys Rev Lett. 2003;90:075503.
   PubMed Web of Science ®Google Scholar
• Werner MM, Patel BA, Talele TT, et al. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines. Bioorg Med Chem. 2015;23:6125–6137.
   PubMed Web of Science ®Google Scholar
• Chu MJ, Wang W, Ren ZL, et al. Discovery of novel triazole-containing pyrazole ester derivatives as potential antibacterial agents. Molecules. 2019;24:E1311.
   PubMed Web of Science ®Google Scholar
• Dias SA, Freire JM, Pérez-Peinado C, et al. New potent membrane-targeting antibacterial peptides from viral capsid proteins. Front Microbiol. 2017;8:775.
   PubMed Web of Science ®Google Scholar
• Mataraci E, Dosler S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2012;56:6366–6371.
   PubMed Web of Science ®Google Scholar
• She P, Luo Z, Chen L, et al. Efficacy of levofloxacin against biofilms of Pseudomonas aeruginosa isolated from patients with respiratory tract infections in vitro. MicrobiologyOpen. 2019;8:e00720.
   PubMed Web of Science ®Google Scholar
• Bang CS, Kinnunen A, Karlsson M, et al. The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide. BMC Microbiol. 2014;14:65.
   PubMed Web of Science ®Google Scholar
• Rolston KV. The use of new and better antibiotics for bacterial infections in patients with leukemia. Clin Lymphoma Myeloma. 2009;9(Suppl 3):S357–63.
   PubMedGoogle Scholar
• Hou HY, Lu WW, Wu KY, et al. Idarubicin is a broad-spectrum enterovirus replication inhibitor that selectively targets the virus internal ribosomal entry site. J Gen Virol. 2016;97:1122–1133.
   PubMed Web of Science ®Google Scholar
• Kinnunen U, Syrjälä H, Koistinen P, et al. Idarubicin inhibits the growth of bacteria and yeasts in an automated blood culture system. Eur J Clin Microbiol Infect Dis. 2009;28:301–303.
   PubMed Web of Science ®Google Scholar
• Kim W, Zhu W, Hendricks GL, et al. A new class of synthetic retinoid antibiotics effective against bacterial persisters. Nature. 2018;556:103–107
   PubMed Web of Science ®Google Scholar
• Kim W, Zou G, Hari TPA, et al. A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 2019;116:16529–16534.
   PubMed Web of Science ®Google Scholar
• Attia SM, Alshahrani AY, AI-Hamamah MA, et al. Dexrazoxane averts idarubicin-evoked genomic damage by regulating gene expression profiling associated with the DNA damage-signaling pathway in BALB/c mice. Toxicol Sci. 2017;160:161–172.
   PubMed Web of Science ®Google Scholar
• Owattanapanich W, Owattanapanich N, Kungwankiattichai S, et al. Efficacy and toxicity of idarubicin versus high-dose daunorubicin for induction chemotherapy in adult acute myeloid leukemia: a systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk. 2018;18:814–821.
   PubMed Web of Science ®Google Scholar
• Błasiak J, Gloc E, Woźniak K, et al. Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostine. Chem Biol Interact. 2002;140:1–18.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu X, Bawa-Khalfe T, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18:1639–1642.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Fylaktakidou K, et al. Amifostine protects mouse liver against radiation-induced autophagy blockage. Anticancer Res. 2018;38:227–238.
   PubMed Web of Science ®Google Scholar
• Sadzuka Y, Egawa Y, Sugiyama T, et al. Effects of 1-methyl-3-propyl-7-butylxanthine (MPBX) on idarubicin-induced antitumor activity and bone marrow suppression. Jpn J Cancer Res. 2000;91:651–657.
   PubMedGoogle Scholar
• Joshi SS, Kuszynski CA, Benner EJ, et al. Amelioration of the cytotoxic effects of chemotherapeutic agents by grape seed proanthocyanidin extract. Antioxid Redox Signal. 1999;1:563–570.
   PubMed Web of Science ®Google Scholar
• Wouters KA, Kremer LC, Miller TL, et al. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol. 2005;131:561–578.
   PubMed Web of Science ®Google Scholar
• Hasan SK, Barba G, Metzler M, et al. Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4; 11) (q21; q23). Genes Chromosones Cancer. 2014;53:248–254. .
   PubMed Web of Science ®Google Scholar
• Montesinos P, González JD, González J, et al. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic acid and anthracycline-based chemotherapy. J Clin Oncol. 2010;28:3872–3879.
   PubMed Web of Science ®Google Scholar
• Pletzer D, Mansour SC, Hancock REW. Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens. PLoS Pathog. 2018;14:e1007084.
   PubMed Web of Science ®Google Scholar
• Smith PA, Koehler MFT, Girgis HS, et al. Optimized arylomycins are a new class of Gram-negative antibiotics. Nature. 2018;561:189–194.
   PubMed Web of Science ®Google Scholar
• Singh A, Singh JV, Rana A, et al. Monocarbonyl curcumin-based molecular hybrids as potent antibacterial agents. ACS Omega. 2019;4:11673–11684
   PubMed Web of Science ®Google Scholar
• Pham TN, Loupias P, Dassonvile-Klimpt A, et al. Drug delivery systems designed to overcome antimicrobial resistance. Med Res Rew. 2019;39:2343–2396.
   PubMed Web of Science ®Google Scholar
• Ter Boo GJ, Grijpma DW, Moriarty TF, et al. Antimicrobial delivery systems for local infection prophylaxis in orthopedic- and trauma surgery. Biomaterials. 2015;52:113–125.
   PubMed Web of Science ®Google Scholar